Sign in Pull a receipt

DBVT

DBV Technologies S.A.

Healthcare · Biotechnology

$176.37 sample

-1.59 (-0.89%) 1D

Market cap

$191.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-23

Alerts

8

Price$176.37 +15.80% 3M daily closessample

177.96150.53

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23SECForm 144 filed
Oct 16INSInsider sell: Chief Financial Officer
Oct 08INSInsider buy: Chief Executive Officer
Sep 30INSInsider sell: General Counsel
Sep 23INSInsider buy: EVP, Operations
Sep 15INSInsider sell: Director
Sep 09INSInsider sell: Director
Aug 31INSInsider buy: Chief Executive Officer

Sign up to see the real DBVT record →

Company facts

SEC EDGAR registration

Name: DBV Technologies S.A.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +32sample, -100 to +100
Reporting currency: USD

Who is positioning in DBVT

sample

Insiders: 14 insider transactions over 90 days, net selling, $688.1M
Congress: 5 members traded over 90 days
Institutions · 13F: 29 funds hold $4.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$6.7B +15.5% y/y

Q4 2024Q3 2026

Inventory$4.0B +19.1% y/y

Q4 2024Q3 2026

Accounts receivable$2.9B +5.5% y/y

Q4 2024Q3 2026

Total debt$8.2B +17.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $98.6B +12.9% 3M
Sample peer B: $82.4B +11.9% 3M
Sample peer C: $80.7B -3.4% 3M
Sample peer D: $63.0B +16.1% 3M
Sample peer E: $191.8B -6.3% 3M